JPH08291044A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPH08291044A
JPH08291044A JP13098195A JP13098195A JPH08291044A JP H08291044 A JPH08291044 A JP H08291044A JP 13098195 A JP13098195 A JP 13098195A JP 13098195 A JP13098195 A JP 13098195A JP H08291044 A JPH08291044 A JP H08291044A
Authority
JP
Japan
Prior art keywords
hydroxybenzamide
formula
skin
dihydroxybenzamide
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13098195A
Other languages
Japanese (ja)
Other versions
JP3545097B2 (en
Inventor
Yoshito Fujiwara
義人 藤原
Masato Nomura
正人 野村
Takahiro Tada
貴広 多田
Kenji Shimomura
健次 下村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP13098195A priority Critical patent/JP3545097B2/en
Publication of JPH08291044A publication Critical patent/JPH08291044A/en
Application granted granted Critical
Publication of JP3545097B2 publication Critical patent/JP3545097B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE: To obtain a cosmetic which contains a hydroxybenzamide derivative, has high skin-lightening action and is effective for roughened skin. CONSTITUTION: This cosmetic contains a compound of the formula (R, is H, methyl; (n) is 1-2) as an active ingredient. The compound of the formula is typically 2-hydroxybenzamide, 4-hydroxybenzamide, 2,6-dihydroxybenzamide, 2,5-dihydroxybenzamide or 4-methoxybenzamide. In addition, oil, a variety of activating agents, a moisturizer and a variety of medicines are properly formulated to give lotion, cream, milk (emulsion), pack or the like. The cosmetic containing the compound of the formula has not only strong skin-lightening action but also strong inhibiting action on active oxygen.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は美白作用が高く、且つ肌
荒れなどに有効な化粧品に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a cosmetic product which has a high whitening effect and is effective against rough skin.

【0002】[0002]

【従来の技術】化粧料の原料として使用できる美白作用
のある物質としては種々の物質が知られているが、有効
性や安全性に問題がある。美白作用が強く、更に皮膚に
対する他の効果も合わせてもつ物質が望まれていた。
Various substances are known as substances having a whitening effect that can be used as a raw material for cosmetics, but there are problems in effectiveness and safety. A substance having a strong whitening effect and also having other effects on the skin has been desired.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、皮膚
に適用して安全であると共に、美白作用が大きく且つ、
更に肌荒れなどに有効な成分を含んだ化粧料を提供する
ことである。
The object of the present invention is to be applied to the skin to be safe and to have a large whitening effect, and
It is another object of the present invention to provide a cosmetic containing an ingredient effective for rough skin.

【0005】[0005]

【課題を解決する手段】本発明者らは、前記の課題を解
決するため、スクリーニングして調べ、化粧品として利
用価値のあるものを検討した。その結果、一般式
Means for Solving the Problems In order to solve the above-mentioned problems, the present inventors have screened and investigated and examined what has a utility value as a cosmetic product. As a result, the general formula

【0006】[0006]

【化1】[Chemical 1]

【0007】(式中のRは水素又はメチル基で、nは1
〜2である)で表される物質が非常に化粧品原料とし
て、或いは医薬部外品としての有効性を有することを見
出した。
(In the formula, R is hydrogen or a methyl group, and n is 1
It has been found that the substance represented by the formula (2) is very effective as a raw material for cosmetics or as a quasi drug.

【0008】この物質は市販されているものもあり、ま
た必要に応じて合成すればよい。合成方法は公知の方法
を用いて作成できる。この物質を他の化粧品原料例えば
スクワラン、ホホバ油等の液状油、ミツロウ、セチルア
ルコール等の固体油、各種の活性剤、グリセリン、1,
3ブチレングリコール等の保湿剤や各種薬剤等を添加し
てさまざまな剤形の化粧料を調整することができる。例
えばローション、クリーム、乳液、パック等で目的に応
じて利用形態を考えればよい。
This substance is commercially available and may be synthesized as needed. The synthetic method can be prepared using a known method. This substance is used as a raw material for other cosmetics such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various active agents, glycerin, 1,
Cosmetics of various dosage forms can be prepared by adding moisturizing agents such as 3-butylene glycol and various chemicals. For example, a lotion, a cream, a milky lotion, a pack, or the like may be used depending on the purpose.

【0009】本発明の物質としての効果は、前記した如
く、第1に肌の美白作用である。
As described above, the effect of the substance of the present invention is, firstly, the whitening effect on the skin.

【0010】第2に活性酸素抑制作用である。空気中に
は酸素があり、これがないと生物(嫌気性のものを除
く)は存在しえない。しかし酸素は紫外線や酵素等の影
響を受けて活性酸素になる。活性酸素は脂肪酸を酸化し
過酸化物を生成させる。生体の生体膜のリン脂質も酸化
させ、障害を与える。その上、生成した過酸化物と活性
酸素はDNAに損傷を与え、老化を促進するといわれて
いる。この活性酸素は、チロシンからメラニンを作る機
構にも影響を与え皮膚の黒化にも関与している。この活
性酸素を抑制することは皮膚にとって重要な言い換えれ
ば化粧料に求められる重要な要素である。本発明の物質
は又この活性酸素抑制作用も有している。
Secondly, it has an effect of suppressing active oxygen. There is oxygen in the air, and without it, living things (except anaerobic ones) cannot exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids and produces peroxides. It also oxidizes and damages the phospholipids of biological membranes in the body. Furthermore, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. This active oxygen also influences the mechanism of making melanin from tyrosine and is also involved in the blackening of the skin. Suppressing this active oxygen is an important factor for the skin, in other words, an important factor required for cosmetics. The substance of the present invention also has this active oxygen suppressing action.

【0011】以下に実際の利用方法である物質の作成方
法である製造例と実施例を記載するが、本発明はこの製
造例や実施例によって何ら限定されるものではない。
The production examples and examples of the method of producing a substance, which is the actual utilization method, are described below, but the present invention is not limited to these production examples and examples.

【0012】製造例1 2、6−ジヒドロキシベンズア
ミド 2、6ジヒドロキシベンゾニトリル(Lancaste
r社製)2.0gを1.0M水酸化ナトリウム/ジメチ
ルスルホキシド混合溶液100mlに溶解し、内温75
±2℃で14時間加熱攪拌した。反応終了後、油分をエ
ーテルで抽出した。収量は54%であった
Production Example 1 2,6-Dihydroxybenzamide 2,6 Dihydroxybenzonitrile (Lancaste)
(manufactured by r company) was dissolved in 100 ml of a 1.0 M sodium hydroxide / dimethyl sulfoxide mixed solution, and the internal temperature was 75
The mixture was heated and stirred at ± 2 ° C for 14 hours. After the reaction was completed, the oil was extracted with ether. The yield was 54%

【0013】製造例2 2、5−ジヒドロキシベンズア
ミド 5−クロロサリチルアミド(東京化成社製)5.0gを
0.65M水酸化ナトリウム水溶液200mlに溶解さ
せた混合溶液をフラスコに入れ窒素気流下で水銀ランプ
(10W−low−pressure mercury
lamp 254nm)を照射しながらマグネチック
スターラーで5時間攪拌した。反応終了後、希塩酸を加
え酸性にした後エーテルで回収した。得られた油分をヘ
キサン:エーテル=9:1の混合溶媒を展開溶媒とする
シリカゲルゲルカラムクロマトグラフィーで精製した。
収量は53%であった。
Production Example 2 2,5-dihydroxybenzamide 5.0 g of 5-chlorosalicylamide (manufactured by Tokyo Chemical Industry Co., Ltd.) was dissolved in 200 ml of a 0.65 M aqueous sodium hydroxide solution, and the mixture was put into a flask and mercury was added under a nitrogen stream. Lamp (10W-low-pressure mercury
The mixture was stirred with a magnetic stirrer for 5 hours while irradiating with (lamp 254 nm). After completion of the reaction, dilute hydrochloric acid was added to acidify, and the mixture was collected with ether. The obtained oil was purified by silica gel gel column chromatography using a mixed solvent of hexane: ether = 9: 1 as a developing solvent.
The yield was 53%.

【0014】製造例3 4−メトキシベンズアミド 4−ヒドロキシベンズアミド(Lancaster社
製)2.0gを攪拌装置、環流冷却管、滴下ロートを付
した4つ口フラスコにとり10%水酸化ナトリウム水溶
液80mlに溶解した後、内温を0℃に保ちながらジメ
チル硫酸3.68gを30分を要して滴下した。滴下終
了後内温100〜105℃で30分加熱環流した。反応
終了後、油分をエーテルで抽出した。得られた油分をヘ
キサン:エーテル=9:1の混合溶媒を展開溶媒とする
シリカゲルゲルカラムクロマトグラフィーで精製した。
収量は23%であった。
Production Example 3 4-Methoxybenzamide 2.0 g of 4-hydroxybenzamide (manufactured by Lancaster) was placed in a four-necked flask equipped with a stirrer, a reflux condenser and a dropping funnel and dissolved in 80 ml of 10% sodium hydroxide aqueous solution. After that, 3.68 g of dimethylsulfate was added dropwise over 30 minutes while keeping the internal temperature at 0 ° C. After completion of the dropping, the mixture was heated to reflux at an internal temperature of 100 to 105 ° C for 30 minutes. After the reaction was completed, the oil was extracted with ether. The obtained oil was purified by silica gel gel column chromatography using a mixed solvent of hexane: ether = 9: 1 as a developing solvent.
The yield was 23%.

【0015】 実施例−1 ローション オリーブ油 0.5 2−ヒドロキシベンズアミド 0.3 ポリオキシエチレン(20E.O)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O)硬化ヒマシ油 2.0 エタノール 10.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 精製水 80.2Example-1 Lotion Olive oil 0.5 2-Hydroxybenzamide 0.3 Polyoxyethylene (20EO) sorbitan monostearate 2.0 Polyoxyethylene (60EO) hydrogenated castor oil 2.0 Ethanol 10 0.0 1.0% sodium hyaluronate aqueous solution 5.0 Purified water 80.2

【0016】 実施例−2 クリーム A スクワラン 20.0 オリーブ油 2.0 ミンク油 1.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 4−ヒドロキシベンズアミド 0.5 B 精製水 48.4 ポリオキシエチレン(20E.O)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O)硬化ヒマシ油 1.0 グリセリン 5.0 1.0%ヒアルロン酸ナトリウム水溶液 5.0 パラオキシ安息香酸メチル 0.1 AとBをそれぞれ計量し、70℃まで加温し、BにAを
撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30
℃まで冷却した。
Example-2 Cream A Squalane 20.0 Olive Oil 2.0 Mink Oil 1.0 Jojoba Oil 5.0 Beeswax 5.0 Cetostearyl Alcohol 2.0 Glycerin Monostearate 1.0 Sorbitan Monostearate 2. 0 4-hydroxybenzamide 0.5 B Purified water 48.4 Polyoxyethylene (20 EO) sorbitan monostearate 2.0 Polyoxyethylene (60 EO) hydrogenated castor oil 1.0 Glycerin 5.0 1.0 % Aqueous sodium hyaluronate solution 5.0 Methyl paraoxybenzoate 0.1 A and B are each weighed and heated to 70 ° C., A is slowly added to B while stirring, and then 30 while slowly stirring.
Cooled to ° C.

【0017】実施例−3は実施例−1の2−ヒドロキシ
ベンズアミドを製造例1のヒドロキシベンズアミドに変
え作成したもの
Example 3 was prepared by replacing the 2-hydroxybenzamide of Example 1 with the hydroxybenzamide of Production Example 1.

【0018】実施例−4は実施例−2の4−ヒドロキシ
ベンズアミドを製造例2の2,5−ジヒドロキシベンズ
アミドに変え作成したもの
Example 4 was prepared by replacing the 4-hydroxybenzamide of Example-2 with the 2,5-dihydroxybenzamide of Production Example 2.

【0019】実施例−5は実施例−1の2−ヒドロキシ
ベンズアミドを製造例3の4−メトキシベンズアミドに
変え作成したもの
Example-5 was prepared by replacing the 2-hydroxybenzamide of Example-1 with the 4-methoxybenzamide of Production Example3.

【0020】チロシナーゼ活性阻害 (試験方法)マツクルバルン(Mcllvaln)緩衝
液1.8ml、0.05%ドーパ(Dopa)溶液1.
0ml、製造例の15mMジメチルスルホキシド溶液
0.1mlをスクリューバイアルにとり、25℃恒温水
槽中で5分以上放置した。チロシナーゼ溶液(Sigm
a 社製、マッシユルーム由来、以下の測定でチロシナ
ーゼを加えてから2分後対照の吸光度が0.3〜0.5
になるように希釈したもの)0.1mlを加え攪拌し、
セルに移し、25℃で保温した状態で475nmで吸光
度をチロシナーゼを加えてから30秒後から15秒おき
に測定した。対照として、上記試料液のかわりにジメチ
ルスルホキシド0.1mlを加え同様に測定した。この
試験では試料の終濃度は0.5mMとなる。 (計算式) チロシナーゼ活性阻害率(%)=(B−A)/B×10
0 但し A:試料検体の吸光度の傾き B:対照の吸光度の傾き
Inhibition of tyrosinase activity (Test method) 1.8 ml of matsuvalbaln buffer solution, 0.05% dopa solution 1.
0 ml and 0.1 ml of the 15 mM dimethyl sulfoxide solution of Preparation Example were placed in a screw vial and left in a constant temperature water bath at 25 ° C. for 5 minutes or more. Tyrosinase solution (Sigma
A company, derived from Massroom, 2 minutes after tyrosinase was added by the following measurement, the absorbance of the control was 0.3 to 0.5.
0.1 ml (diluted so that
The cells were transferred to a cell and the absorbance was measured at 475 nm every 15 seconds from 30 seconds after the addition of tyrosinase while keeping the temperature at 25 ° C. As a control, 0.1 ml of dimethyl sulfoxide was added instead of the above sample solution, and the same measurement was performed. In this test, the final concentration of the sample is 0.5 mM. (Calculation formula) Tyrosinase activity inhibition rate (%) = (B−A) / B × 10
0 where A: slope of absorbance of sample specimen B: slope of absorbance of control

【0021】[0021]

【表1】 [Table 1]

【0022】(活性酸素抑制試験効果)活性酸素を抑制
する効果を測定する方法は各種あるが、今回和光純薬の
SODテストワコーを用いて実験した。発色試薬を1.
0ml、試料(製造例の15mMジメチルスルホキシド
溶液)を0.1mlとり37℃で恒温にしたのち、酵素
液1.0mlを加えて攪拌したのち、37℃、20分間
放置後、反応停止液を2.0mlを加えて560nmで
吸光度を測定した。この試験では試料の終濃度は0.3
75mMとなる。
(Effect of Active Oxygen Suppression Test) There are various methods for measuring the effect of suppressing active oxygen, but this time an experiment was performed using SOD Test Wako of Wako Pure Chemical. Use the coloring reagent 1.
0 ml and 0.1 ml of the sample (15 mM dimethylsulfoxide solution of the preparation example) were taken and kept at 37 ° C. to a constant temperature, 1.0 ml of enzyme solution was added and stirred, and after leaving at 37 ° C. for 20 minutes, the reaction stop solution was added to 2 ml. 0.0 ml was added and the absorbance was measured at 560 nm. In this test, the final concentration of the sample is 0.3
It becomes 75 mM.

【0023】[0023]

【表2】 [Table 2]

【0024】[0024]

【効果】一般式[Effect] General formula

【化1】(式中のRは水素又はメチル基で、nは1〜2
である)で表される物質例えば、2−ヒドロキシベンズ
アミド、4−ヒドロキシベンズアミド、2,6−ジヒド
ロキシベンズアミド、2,5−ジヒドロキシベンズアミ
ド、4−メトキシベンズアミドを含む化粧品は美白作用
が強いばかりではなく、強い活性酸素抑制作用を有し化
粧品原料として最適である。
(In the formula, R is hydrogen or a methyl group, and n is 1-2.
The cosmetics containing, for example, 2-hydroxybenzamide, 4-hydroxybenzamide, 2,6-dihydroxybenzamide, 2,5-dihydroxybenzamide, 4-methoxybenzamide have not only a strong whitening effect, It has a strong inhibitory effect on active oxygen and is most suitable as a raw material for cosmetics.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 一般式 【化1】 (式中のRは水素又はメチル基で、nは1〜2である)
で表される物質を含む化粧品
1. A compound of the general formula (R in the formula is hydrogen or a methyl group, and n is 1 to 2)
Cosmetics containing the substance represented by
【請求項2】 2−ヒドロキシベンズアミド、4−ヒド
ロキシベンズアミド、2,6−ジヒドロキシベンズアミ
ド、2,5−ジヒドロキシベンズアミド、4−メトキシ
ベンズアミドである請求項1の化粧品
2. The cosmetic product according to claim 1, which is 2-hydroxybenzamide, 4-hydroxybenzamide, 2,6-dihydroxybenzamide, 2,5-dihydroxybenzamide, or 4-methoxybenzamide.
JP13098195A 1995-04-19 1995-04-19 Skin cosmetics Expired - Fee Related JP3545097B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13098195A JP3545097B2 (en) 1995-04-19 1995-04-19 Skin cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13098195A JP3545097B2 (en) 1995-04-19 1995-04-19 Skin cosmetics

Publications (2)

Publication Number Publication Date
JPH08291044A true JPH08291044A (en) 1996-11-05
JP3545097B2 JP3545097B2 (en) 2004-07-21

Family

ID=15047130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13098195A Expired - Fee Related JP3545097B2 (en) 1995-04-19 1995-04-19 Skin cosmetics

Country Status (1)

Country Link
JP (1) JP3545097B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064206A3 (en) * 2000-02-29 2002-08-29 Integriderm Inc Inhibitors of melanocyte tyrosinase as topical skin lighteners

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100680584B1 (en) * 2005-08-19 2007-02-08 (주)아모레퍼시픽 Hydroxybenzamide derivatives, the method for preparing thereof and the cosmetic composition containing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064206A3 (en) * 2000-02-29 2002-08-29 Integriderm Inc Inhibitors of melanocyte tyrosinase as topical skin lighteners

Also Published As

Publication number Publication date
JP3545097B2 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
JPH07316034A (en) Method of using resorcinol derivative mono-or di-substitutedat 4,4-and 5-,or 4-and 6-positions for cosmetic composition or dermal medicinal composition having depigmentation action
JPH09263534A (en) Promoter for melanogenesis
JP2000128762A (en) Melanogenesis inhibitor and skin preparation for external use for beautifying containing the same
JPH1171294A (en) Collagenase inhibitor
JPH1025238A (en) Preparation for external use for skin
JPH068249B2 (en) Topical agent for suppressing melanin production
JP2001163759A (en) Beautifying and whitening agent, and preparation for external use for skin containing the same
JPH10265325A (en) Melanin formation suppressant and skin whitening cosmetic material
JPH0892053A (en) External preparation for skin
JP3545097B2 (en) Skin cosmetics
JPH0899891A (en) Skin external agent
JPH06329516A (en) Cosmetic
JP2001010926A (en) Bleaching agent
JP2004168732A (en) Active oxygen-scavenging agent, inhibitor for synthesis promotion/decomposition of hyaluronic acid, and aquaporin synthesis promotor
JPH0977655A (en) Skin preparation for external use
JPH0656641A (en) Cosmetic
JP3452393B2 (en) Cosmetics
JPH01207225A (en) Cosmetic for hair
JPH06145040A (en) Melanogenesis-suppressing agent
JPH0761905A (en) Beautifully whitening cosmetic
JPH0597653A (en) Cosmetic
JP3120086B2 (en) Hair cosmetics for prevention of gray hair and blackening of gray hair
JPH0867617A (en) Cosmetic
JP3150841B2 (en) External preparation for skin
JP3461921B2 (en) Cosmetics

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040121

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040203

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040224

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040406

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040407

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees